164 related articles for article (PubMed ID: 11073717)
1. Genomic organization, expression, and alternate splicing of the mouse fatty aldehyde dehydrogenase gene.
Lin Z; Carney G; Rizzo WB
Mol Genet Metab; 2000 Nov; 71(3):496-505. PubMed ID: 11073717
[TBL] [Abstract][Full Text] [Related]
2. Sjögren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2).
Rizzo WB; Carney G
Hum Mutat; 2005 Jul; 26(1):1-10. PubMed ID: 15931689
[TBL] [Abstract][Full Text] [Related]
3. Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
Haug S; Braun-Falco M
Gene Ther; 2006 Jul; 13(13):1021-6. PubMed ID: 16525484
[TBL] [Abstract][Full Text] [Related]
4. RNA-based mutation screening in German families with Sjögren-Larsson syndrome.
Kraus C; Braun-Quentin C; Ballhausen WG; Pfeiffer RA
Eur J Hum Genet; 2000 Apr; 8(4):299-306. PubMed ID: 10854114
[TBL] [Abstract][Full Text] [Related]
5. Genomic organization and tissue-specific expression of splice variants of mouse organic anion transporting polypeptide 2.
Ogura K; Choudhuri S; Klaassen CD
Biochem Biophys Res Commun; 2001 Feb; 281(2):431-9. PubMed ID: 11181066
[TBL] [Abstract][Full Text] [Related]
6. Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene.
De Laurenzi V; Rogers GR; Hamrock DJ; Marekov LN; Steinert PM; Compton JG; Markova N; Rizzo WB
Nat Genet; 1996 Jan; 12(1):52-7. PubMed ID: 8528251
[TBL] [Abstract][Full Text] [Related]
7. Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjögren-Larsson syndrome.
Rizzo WB; Lin Z; Carney G
Chem Biol Interact; 2001 Jan; 130-132(1-3):297-307. PubMed ID: 11306053
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the human aldehyde reductase gene and promoter.
Barski OA; Gabbay KH; Bohren KM
Genomics; 1999 Sep; 60(2):188-98. PubMed ID: 10486210
[TBL] [Abstract][Full Text] [Related]
9. Genomic organization and expression of the human fatty aldehyde dehydrogenase gene (FALDH).
Rogers GR; Markova NG; De Laurenzi V; Rizzo WB; Compton JG
Genomics; 1997 Jan; 39(2):127-35. PubMed ID: 9027499
[TBL] [Abstract][Full Text] [Related]
10. An Indian family with Sjögren-Larsson syndrome caused by a novel ALDH3A2 mutation.
Sakai K; Akiyama M; Yanagi T; Nampoothiri S; Mampilly T; Sunitha V; Shimizu H
Int J Dermatol; 2010 Sep; 49(9):1031-3. PubMed ID: 20883264
[TBL] [Abstract][Full Text] [Related]
11. Human fatty aldehyde dehydrogenase gene (ALDH10): organization and tissue-dependent expression.
Chang C; Yoshida A
Genomics; 1997 Feb; 40(1):80-5. PubMed ID: 9070922
[TBL] [Abstract][Full Text] [Related]
12. Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene.
Aoki K; Kato J; Shoemaker MT; Moss J
Gene; 2005 May; 351():83-95. PubMed ID: 15893437
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome.
Haug S; Braun-Falco M
Arch Dermatol Res; 2005 Jun; 296(12):568-72. PubMed ID: 15834613
[TBL] [Abstract][Full Text] [Related]
14. Structural organization of the human complexin 2 gene (CPLX2) and aspects of its functional activity.
Raevskaya NM; Dergunova LV; Vladychenskaya IP; Stavchansky VV; Oborina MV; Poltaraus AB; Limborska SA
Gene; 2005 Oct; 359():127-37. PubMed ID: 16162394
[TBL] [Abstract][Full Text] [Related]
15. Genomic organization and structure of the 5'-flanking region of the TEX101 gene: alternative promoter usage and splicing generate transcript variants with distinct 5'-untranslated region.
Tsukamoto H; Takizawa T; Takamori K; Ogawa H; Araki Y
Mol Reprod Dev; 2007 Feb; 74(2):154-62. PubMed ID: 16941676
[TBL] [Abstract][Full Text] [Related]
16. Sjögren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2.
Carney G; Wei S; Rizzo WB
Hum Mutat; 2004 Aug; 24(2):186. PubMed ID: 15241804
[TBL] [Abstract][Full Text] [Related]
17. Human transcription factor Sp3: genomic structure, identification of a processed pseudogene, and transcript analysis.
Moran KM; Crusio RH; Chan CH; Grekova MC; Richert JR
Gene; 2004 Oct; 341():235-47. PubMed ID: 15474306
[TBL] [Abstract][Full Text] [Related]
18. Gene structure and expression of the mouse dyskeratosis congenita gene, dkc1.
Heiss NS; Bächner D; Salowsky R; Kolb A; Kioschis P; Poustka A
Genomics; 2000 Jul; 67(2):153-63. PubMed ID: 10903840
[TBL] [Abstract][Full Text] [Related]
19. The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.
Rizzo WB; Carney G; Lin Z
Am J Hum Genet; 1999 Dec; 65(6):1547-60. PubMed ID: 10577908
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning, genomic structure, and expression analysis of the mouse transcriptional intermediary factor 1 gamma gene.
Yan KP; Dollé P; Mark M; Lerouge T; Wendling O; Chambon P; Losson R
Gene; 2004 Jun; 334():3-13. PubMed ID: 15256250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
